BGLC (BioNexus Gene Lab) Institutional Ownership: 0.01% (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BGLC BioNexus Gene Lab Corp BGLC
58 GF Score
Price $1.63
GF Value $2.17
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is BioNexus Gene Lab Institutional Ownership?

BioNexus Gene Lab BGLC -2.40% 58 Institutional Ownership is 0.01% as of Jul. 21, 2026. GuruFocus rates BGLC with a GF Score™ of 58/100 and a GF Value™ of $2.17 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BioNexus Gene Lab's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BioNexus Gene Lab's Insider Ownership is 96.27%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BioNexus Gene Lab's Float Percentage Of Total Shares Outstanding is 83.62%.

BioNexus Gene Lab Institutional Ownership Historical Data

* Premium members only.

The historical data trend for BioNexus Gene Lab's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioNexus Gene Lab Institutional Ownership Chart

BioNexus Gene Lab Historical Data

The historical data trend for BioNexus Gene Lab can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.13 0.13 0.13 0.10 0.10 0.10 0.10 0.10 0.10 0.10
BGLC
58GF Score
BioNexus Gene Lab Corp BGLC
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioNexus Gene Lab Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.01% mean?
BioNexus Gene Lab (BGLC) has a Institutional Ownership of 0.01% as of Jul. 21, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on BioNexus Gene Lab and its competitors.
Is BioNexus Gene Lab's Institutional Ownership too high?
BioNexus Gene Lab's current Institutional Ownership is 0.01%. Overall, BioNexus Gene Lab has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioNexus Gene Lab's Institutional Ownership compare to QGAI and VYST?
BioNexus Gene Lab's Institutional Ownership of 0.01% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Chemicals company?
A good Institutional Ownership depends on the Chemicals industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on BioNexus Gene Lab and its competitors. BioNexus Gene Lab's current Institutional Ownership is 0.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioNexus Gene Lab stock overvalued right now?
Based on GuruFocus' analysis, BioNexus Gene Lab (BGLC) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.17, compared to a current price of $1.63 — trading 24.9% below its estimated fair value. The current Institutional Ownership is 0.01%. BioNexus Gene Lab's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For BioNexus Gene Lab (BGLC), the current Institutional Ownership is 0.01% as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioNexus Gene Lab (BGLC) Overvalued in 2026?

Based on GuruFocus' analysis, BioNexus Gene Lab stock appears to be undervalued. The current stock price of $1.63 is trading 24.9% below its estimated GF Value™ of $2.17. GuruFocus considers BioNexus Gene Lab to be Modestly Undervalued.

Key valuation signals for BGLC:

  • Institutional Ownership: 0.01%
  • GF Value™: $2.17 vs. price of $1.63 (24.9% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the BGLC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioNexus Gene Lab Business Description

Address No.5 Jln Bangsar Utama 1, Unit A-28-7, Level 28, Tower A, Menara UOA Bangsar, Kuala Lumpur, SGR, MYS, 59200
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
58GF Score

Get the complete analysis for BGLC

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.63
Price
$2.17
GF Value